In the biological, disease-oriented model of psychiatric illness, psychotropic medications are the frontline treatment. These medications have enabled many consumers of psychiatric mental health care to obtain relief from severe and disabling symptoms. Allegiance to the model continues as both consumers and psychiatric mental health professionals anxiously await approval of newer medications promising even greater benefits.
